Key result
Selenium supplementation undergoes proof-of-concept testing for selenium-deficient PPCM.
Why the study?
Selenium deficiency is common in some African PPCM patients, but selenium supplementation in PPCM has not been studied.
Key points are not available for this paper at this time.
Population
159 PPCM patients screened in Nigeria
Comparison
Selenium supplementation vs no supplementation in selenium-deficient PPCM patients
Design
Proof-of-concept trial
No practice change for peripartum cardiomyopathy; leaves open efficacy of selenium repletion in deficient patients.
Studies suggest that selenium deficiency is common in some African peripartum cardiomyopathy (PPCM) patients, but selenium supplementation in PPCM has not been studied. We assessed the effects of selenium supplementation in PPCM patients who had selenium deficiency in Nigeria We screened 159 PPCM
No takes yet. Share an insight, caveat, or question.
Karaye et al. (2020) studied this question. Selenium supplementation was evaluated in a proof-of-concept trial screening 159 Nigerian patients with peripartum cardiomyopathy and selenium deficiency.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: